Description: Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
Home Page: www.medios.ag
Heidestrasse 9
Berlin,
10557
Germany
Phone:
49 30 232 5668 00
Officers
| Name | Title |
|---|---|
| Mr. Matthias Gaertner | CEO & Chairman of the Exec. Board |
| Mr. Falk Neukirch | CFO & Member of Exec. Board |
| Mr. Christoph Prußeit | Chief Innovation Officer & Member of Exec. Board |
| Ms. Mi-Young Miehler | COO & Member of Exec. Board |
| Claudia Nickolaus | Head of Investor & PR |
Exchange: XETRA
Country: DE
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 38.3404 |
| Price-to-Book MRQ: | 1.0855 |
| Price-to-Sales TTM: | 0.2788 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 514 |